Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopenia.
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts.
James F
JF
Gilmore
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts.
Christopher D
CD
Adams
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts.
Rachel M
RM
Blum
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts.
John
J
Fanikos
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts.
Beth
B
Anne Hirning
Department of Pharmacy Services, Brigham and Women's Hospital, Boston, Massachusetts.
Lina
L
Matta
D000368:Aged; D000369:Aged, 80 and over; D000991:Antithrombins / Q000097:blood / Q000627:therapeutic use*; D001120:Arginine / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D054796:Drug Dosage Calculations; D016903:Drug Monitoring; D005260:Female; D006493:Heparin / Q000009:adverse effects; D006629:Hirudins / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000097:blood / Q000627:therapeutic use*; D010875:Pipecolic Acids / Q000097:blood / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000097:blood / Q000627:therapeutic use; D013449:Sulfonamides; D016019:Survival Analysis; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy* / Q000401:mortality; D016896:Treatment Outcome
D000991:Antithrombins; D006629:Hirudins; D010446:Peptide Fragments; D010875:Pipecolic Acids; D011994:Recombinant Proteins; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban; C074619:bivalirudin